Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 12 million stock options ahahahahahaba

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon Sep 25, 2024 3:30pm

93 Views

Post# 36240844

RE:RE:RE:12 million stock options ahahahahahaba

Man you re dense. It won't ever get to 4x when u dilute it with 30 million plus options at 25 cents. Again a bunch of people thinking about themselves when the number 1 fiduciary responsibility is to the company. With no performance incentives wow just wow. Seriously those should have been tied to getting BTD this year but then they'd all be out 12 million options.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments